BCL2L1 and Stroke: Our data have shown that edaravone up-regulated Bcl-XL expression and inhibited Bax expression in parkinsonian rats, helping understand the underlying mechanisms of edaravone's anti-apoptosis effects, similar to the findings in stroke animal models [36], [37].